RT @tjelle13: @emily_fri Holy https://t.co/P62stMNNRS
RT @jim_crawfurd: @ERSimMonkey @emily_fri @Ryan725 Reference for the Cochrane article is below. Doesn’t seem as convincing as the UpToDate…
@ERSimMonkey @emily_fri @Ryan725 Reference for the Cochrane article is below. Doesn’t seem as convincing as the UpToDate take on it suggests, but given that magnesium is cheap and well-tolerated, seems reasonable to give it a go. https://t.co/Hcq5oAyDep
Para los detractores de una medida tan sencilla y económico, siempre ayuda y poco probable que haga daño. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease - Ni, H - 2022 | Cochrane Library https://t.co/Uc74Ea4AAx
静注マグネシウム,重症COPD増悪でも効くってよ https://t.co/S5C4TR10Zm
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
Sulfate de magnésium pour les exacerbations aiguës de la maladie pulmonaire obstructive chronique - Ni, H - 2022 |Bibliothèque Cochrane https://t.co/qOmhZMTc8f
RT @SFMU_MS: Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2022 May https…
RT @SFMU_MS: Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2022 May https…
Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2022 May https://t.co/6P52PjgaqE https://t.co/baLmcq68bh
Our residency program is going to discuss the Cochran meta-analysis of magnesium sulphate for acute COPD exacerbations in Journal Club. Does #MedTwitter have any criticisms, concerns or tips about this particular topic or meta-analysis in general? https:/
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @drsmparker: @EMSwami Weak evidence, they urge caution and more studies needed. Not recommending routine use of IV Mg in COPD yet….. htt…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMKeFoundation: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/tebehAnGfA…
RT @FABIOVARON: Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease - Ni, H - 2022 | Cochrane Library https:…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/tebehAnGfA ⬇️🏥: OR 0.45 NNT = 7 ⬇️🏥LOS: 2.7 days No benefit in reduction of NIV Nebulized Mg does not appear to carry same benefits https://t.co/ln
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @FABIOVARON: Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease - Ni, H - 2022 | Cochrane Library https:…
RT @FABIOVARON: Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease - Ni, H - 2022 | Cochrane Library https:…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease - Ni, H - 2022 | Cochrane Library https://t.co/O5UxKjPs0n
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
Once again magnesium proving itself as the #thepeopleselectrolyte
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @drsmparker: @EMSwami Weak evidence, they urge caution and more studies needed. Not recommending routine use of IV Mg in COPD yet….. htt…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @drsmparker: @EMSwami Weak evidence, they urge caution and more studies needed. Not recommending routine use of IV Mg in COPD yet….. htt…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
@EMSwami Weak evidence, they urge caution and more studies needed. Not recommending routine use of IV Mg in COPD yet….. https://t.co/flqTymNF6l
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
🫁
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
RT @EMSwami: Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR…
Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR 0.45 NNT = 7 ⬇️🏥LOS: 2.7 days No benefit in reduction of NIV Nebulized Mg does not appear to carry same benefits https://t.co/0C
Sulfato de magnesio (SM) para las exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica: El SM intravenoso se asocia con menos ingresos hospitalarios, menor duración del ingreso y mejores puntuaciones de disnea respecto del placebo... https:/
RT @Links_Medicus: Systematic Review: Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease. – via @CochraneLi…
Systematic Review: Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease. – via @CochraneLibrary https://t.co/ViLIfeE3ec Summary: https://t.co/1kX3jKsulu
RT @CochraneLibrary: Is magnesium sulfate effective for #COPD flare‐ups? @CochraneAirways systematic review evaluates the evidence from 11…
RT @CochraneLibrary: Is magnesium sulfate effective for #COPD flare‐ups? @CochraneAirways systematic review evaluates the evidence from 11…
RT @CochraneLibrary: Is magnesium sulfate effective for #COPD flare‐ups? @CochraneAirways systematic review evaluates the evidence from 11…